Suzy Farid Helps Shape G7 100 Days Mission
7 December 2021
UCL Biochemical Engineering's Professor Suzy Farid played a key role in helping the UK implement the G7 100 days mission. The project aims to reduce the impact of future pandemics by making diagnostics, therapeutics and vaccines available within 100 days.
We're very proud to announce that Suzy attended a roundtable hosted by the UK Government Chief Scientific Advisor Sir Patrick Vallance back in November. Suzy provided input relating to the goals for developing new monoclonal antibody therapies during a pandemic. Two of her papers were cited in the report and her contribution helped the government set evidence-based cost targets for this type of therapy.
Links
- Read the full 100 Days Mission Implementation Report here
- Professor Suzy Farid's UCL IRIS profile
- End-to-end continuous bioprocessing: Impact on facility design, cost of goods, and cost of development for monoclonal antibodies. Biotechnology and Bioengineering, 118(9). Mahal, H., Branton, H. and Farid, S.S. (2021).
- Process economics evaluation of call-free synthesis for the commercial manufacture of antibody drug conjugates, Stamatis, C. and Farid, S.S. (2021).